The aim of this study is to investigate the effect of cognitive training combined with physical exercise on cognitive function, physical performance and frailty indicators in the hemodialysis population.
The prevalence of cognitive impairment in hemodialysis (HD) patients is extremely high. Despite the well-documented benefits of interventions on cognitive function, there is a widespread call for effective strategies that will show the long-term consequences in patients undergoing dialysis. A randomized controlled intervention trial to examine the effects of a combined non-pharmacological intervention in the form of intradialytic physical exercise and intradialytic cognitive training on cognitive function, indicators of frailty, and physical performance measures in HD patients will be conducted. The group of patients receiving the study intervention will be compared to the control group receiving standard HD care. The duration of the intervention will be 12 weeks (3 days a week). We will use sensitive instruments (cognitive domain tests) to assess cognitive functions. The primary outcome of the study at 12 weeks will be performance on the Alertness subtest of the computerized Test of Attentional Performance. Secondary study outcomes will be: Performance in other domains of cognitive function (executive function, psychomotor speed, information processing efficiency, working memory, attention), physical fitness (10 repetition sit-to-stand test, timed up and go test, handgrip strength test, spontaneous gait speed, Stork balance test), and assessment of frailty (Edmonton Frail Scale). Study outcomes will be assessed at baseline and immediately after the 12-week intervention. This study will be among the first to test the synergistic effects of a uniquely designed physical exercise and cognitive training intervention on functional status in HD patients.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Enrollment
44
12 weeks (3 times a week): patients will cycle on an adapted ergometer during their dialysis procedure. The exercise program will be run by kinesiologists. Participants will start with 15 minutes of cycling and then gradually increase the time and intensity. After the physical exercise session, they will continue with cognitive training. This training will be done on a tablet computer on a CogniFit platform (\~30 minutes). The "brain games" on mentioned platform automatically adapt to individual cognitive abilities.
University Medical Centre
Ljubljana, Osrednjeslovenska, Slovenia
Change in Test of Attentional Performance (TAP) score
The Test of Attentional Performance (TAP) is a software package that can be used primarily to examine attention functions. The rationale for the selection of the main outcome: low learning effect, most probably affected by physical exercise, attention is one of the most affected cognitive domains in dialysis patients. From the TAP test battery, subtests Alertness, Selective attention, and Divided attention will be included.
Time frame: baseline, after 12 weeks
Change in Montreal Cognitive Assessment (MoCA) score
Montreal Cognitive Assessment (MoCA) is a global cognitive function assessment tool covering eight cognitive domains and is used to screen patients for cognitive impairment.
Time frame: baseline, after 12 weeks
Change in Trail Making Test A and B score
The psychomotor speed and executive function will be measured by Trail Making Test A and B.
Time frame: baseline, after 12 weeks
Change in Symbol Digit Modalities Test (SDMT) score
Symbol Digit Modalities Test (SDMT) will be used to assess the psychomotor speed, efficiency of information processing, ability to switch between mental sets of the information and to maintain and manipulate information in working memory. It is a reliable and valid test for assessing information processing speed and efficiency and executive functioning domains.
Time frame: baseline, after 12 weeks
Change in 10 repetition sit-to-stand test time
Performance of the sit-to-stand test involves activation of the lower limb muscles; the test measures lower limb strength. Participants are required to 10 times stand up from and sit down on an armless chair as quickly as possible. Their arms should be folded across their chest.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: baseline, after 12 weeks
Change in Stork balance test time
Stork balance test time as a measure of balance.
Time frame: baseline, after 12 weeks
Change in frailty score
Frailty indicator will be assessed by the Edmonton Frail Scale (EFS). The EFS score ranges from zero to 17 points. Severe Frailty is defined as a score of 12-17 possible points; apparent vulnerability is a score of 6-11 points; and non-frail is a score of 5 or less points.
Time frame: baseline, after 12 weeks
Change in timed-up-and go (TUG) test time
The Timed Up and Go (TUG) test is a simple evaluative test used to measure functional mobility. It will be used to estimate risk of falling and ability to maintain balance while walking and while walking and talking (TUG-dual).
Time frame: baseline, after 12 weeks
Change in handgrip strength (HGS) test
Handgrip strength test as a measure of upper body strength (in kilograms).
Time frame: baseline, after 12 weeks
Change in Kidney Disease Quality of Life Short Form (KDQoL-SF) score
Kidney Disease Quality of Life Short Form (KDQOL-SF) as a measure of quality of life. The scoring procedure first transforms the raw precoded numeric values of items to a 0-100 possible range, with higher transformed scores always reflecting better quality of life. Scores are evaluated according to summary scores: a mental component summary (MCS) and a physical component summary (PCS).
Time frame: baseline, after 12 weeks
Change in spontaneous gait speed
Spontaneous gait speed test (4 meters) as a measure of functional mobility (in m/s).
Time frame: baseline, after 12 weeks
Change in Brain-derived neurotrophic factor (BDNF) concentration
BDNF is a neurotrophic protein that promotes neurons' survival and differentiation.
Time frame: baseline, after 12 weeks
Change in Interleukin-6 concentration
Interleukin-6 serum concentration
Time frame: baseline, after 12 weeks
Change in C-reactive protein (CRP) concentration
C-reactive protein serum concentration
Time frame: baseline, after 12 weeks
Change in hemoglobin concentration
Hemoglobin blood concentration
Time frame: baseline, after 12 weeks
Change in urea concentration
Urea serum concentration
Time frame: baseline, after 12 weeks
Change in phosphate concentration
Phosphate serum concentration
Time frame: baseline, after 12 weeks
Change in albumin concentration
Albumin serum concentration
Time frame: baseline, after 12 weeks
Change in fat tissue index
Fat tissue index measured by bioimpedance analysis (BCM Fresenius Medical Care)
Time frame: baseline, after 12 weeks
Change in lean tissue index
Lean tissue index measured by bioimpedance analysis (BCM Fresenius Medical Care)
Time frame: baseline, after 12 weeks
Change in mental fatigue
Mental fatigue measured by Visual Analogue Scale (M-VAS) ranged 0-100, where higher score indicates higher mental fatigue.
Time frame: baseline, after 12 weeks
Change in hematocrit concentration
Hematocrit blood concentration
Time frame: baseline, after 12 weeks
Change in creatinine concentration
Creatinine serum concentration
Time frame: baseline, after 12 weeks
Change in sodium concentration
Sodium serum concentration
Time frame: baseline, after 12 weeks
Change in potassium concentration
Potassium serum concentration
Time frame: baseline, after 12 weeks